Maintenance Treatment After Rituxan for ANCA-associated Vasculitis Not Needed, Researchers Argue
Certain types of patients with ANCA-associated vasculitis do not require maintenance therapy if treated with a specific Rituxan (rituximab) approach, according to researchers at the University of Turin in Italy who followed patients for up to 11 years. The study, albeit small, might clear up some confusion about the…